STOCK TITAN

P3 HEALTH PARTNERS INC - PIII STOCK NEWS

Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.

P3 Health Partners Inc (PIII) delivers physician-led population health management through integrated community care networks. This news hub provides investors and healthcare professionals with essential updates on the company's initiatives in value-based care models and patient-centered healthcare solutions.

Access real-time updates on earnings reports, strategic partnerships, and operational developments. Our curated collection features verified press releases and analysis of PIII's community health programs, care coordination advancements, and leadership in population health management.

Key coverage includes:
- Financial performance and market position updates
- Collaborative care network expansions
- Innovations in chronic disease management
- Physician engagement initiatives
- Value-based care model implementations

Bookmark this page for continuous access to PIII's latest developments in healthcare services. Monitor how their physician-led approach transforms community health outcomes through coordinated care strategies.

Rhea-AI Summary

P3 Health Partners Inc. announced that Dr. Aric Coffman has been appointed as the new CEO, effective May 8, 2024, succeeding Dr. Sherif Abdou. Dr. Abdou will continue as a Strategic Advisor and Board member. Dr. Coffman brings extensive experience in value-based care and healthcare delivery for seniors, with a successful track record in leadership roles. The appointment reflects the company's focus on growth and success in the value-based care sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
-
Rhea-AI Summary

P3 Health Partners Inc. (NASDAQ: PIII) announced the schedule for its first quarter 2024 earnings release and conference call. The financial results will be released on May 8, 2024, followed by a conference call to discuss the results at 1:30pm PT/ 4:30pm ET on the same day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024, at 1:30 pm Eastern Time. Webcast available on P3's Investor Relations Website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (PIII) reports a 21% year-over-year revenue growth, exceeding 2023 guidance, with affirmations for 2024. The company anticipates achieving Adjusted EBITDA positive in 2024. Financial results for Q4 2023 show strong performance with total revenue up by 34% and capitated revenue up by 35%. Full-year 2023 results indicate total revenue growth of 21% compared to the previous year, with positive increases in key financial metrics. Despite a net loss, P3 remains optimistic about future growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.08%
Tags
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) plans to release its financial results for Q4 and full year 2023 on March 28, 2024, reaffirming its 2024 guidance. The company observed stable utilization trends early in 2024, with strong membership growth and plans to source additional debt capital for growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
44.27%
Tags
conferences earnings
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) announces leadership presentation at KeyBanc LifeSciences & Medtech Investor Forum. Webcast available on Investor Relations Website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to participate in Jefferies Value Based Healthcare Summit in Miami Beach, Florida. Investor meetings scheduled for March 11th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) is set to present at the TD Cowen 44th Annual Health Care Conference in Boston. The management will conduct a webcast of the fireside chat, available on P3's Investor Relations Website. The presentation is scheduled for Monday, March 4, 2024, at 10:30 am Eastern Time, with a replay accessible for 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) will participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. The company's management will host investor meetings on February 13th and 14th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reaffirms guidance for 2023 and announces guidance for 2024 at J.P. Morgan’s 42nd Annual Healthcare Conference. The company expects to achieve meaningful profitability in 2024, with a robust pipeline of strategic partnerships driving growth and momentum across key performance metrics. Dr. Sherif Abdou, co-founder and CEO, and Atul Kavthekar, CFO, are scheduled to present on January 10, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
P3 HEALTH PARTNERS INC

Nasdaq:PIII

PIII Rankings

PIII Stock Data

30.15M
1.24M
62.08%
13.27%
1.04%
Medical Care Facilities
Services-health Services
Link
United States
CHICAGO